Cap Analogs
CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt
Quick view. We supply CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt as a trinucleotide m7G cap analog containing m6A and 2'-OMe features for mRNA epitranscriptomic/cap SAR. CAS 71340-22-2. Catalog target purity: ≥95%.
Product profile
CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt is classified as rna cap analog or cap-related nucleotide (Formula C33H45N15O24P4; molecular weight 1159.7).
CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt can support enzyme-substrate, in-vitro transcription, polymerase-screening or analytical-reference studies as appropriate to its phosphate state.
For CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt, modification benefits are context-dependent; transcript length, substitution level, enzyme system and analytical purity can change the observed outcome.
Names and search terms
Confirmed or normalized name variants
- CAP GAG(m6A)
- m7G(5')ppp(5')(2'OMe,m6A)pG
Useful catalog search terms
- CAS 71340-22-2
- RNA cap analog or cap-related nucleotide
- Cap Analogs
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
- We release this product against the stated purity specification; the lot-specific CoA provides the result and analytical basis.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- m7Gpppm6AmpG is a trinucleotide mRNA 5’ cap analogs. m7Gpppm6AmpG can be used for RNA synthesis in vitro.
- Typical qualification includes identity, salt/counterion, assay basis, water content and enzyme compatibility.
- Related uses include LC-MS/HPLC method development and comparison with native or modified nucleotide controls.
Product-specific evaluation notes
Potential advantages
- Base modifications can tune RNA stability, translation behavior, duplex properties or analytical discrimination versus native bases.
- Cap analog selection can influence capping efficiency, orientation and downstream translation-related performance.
Method limitations
- Modification benefits are context-dependent; transcript length, substitution level, enzyme system and analytical purity can change the observed outcome.
- Capping outcome depends on polymerase system, cap-to-NTP ratio, transcript design and purification method.
These points describe CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
ARCA
Cap Analogs · CAS: 400806-46-4
BX-CA-0002CAP A(5')ppp(5')(2'-OMeA)pG Ammonium Salt
Cap Analogs · CAS: N/A
BX-CA-0003CAP 4 m7G(UNA)(5')ppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: N/A
BX-CA-0004CAP 5 m7G(5')vppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: 3038327-80-6
BX-CA-0005CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: 2645354-92-1
BX-CA-0006CAP 7 m7G(HNA)(5')ppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: N/A
Frequently asked questions
Can the package size for CAP GAG(m6A) m7G(5')ppp(5')(2'OMe,m6A)pG Ammonium Salt be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-CA-0013 and CAS 71340-22-2, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Cap Analogs product family and its named chemistry.